The recent story of an American sailor who was rescued by Filipino seafarers may aptly be an application of the “Good Samaritan at Sea” doctrine or the obligation to render…
Read More
Time and again, the Supreme Court has held that cardiovascular disease, coronary artery disease, and other heart ailments of seafarers are work-related and, thus, compensable. Seafarers have a higher rate of…
Read More
A seafarer still undergoing medical treatment beyond the 120/240-day period despite an assessment from the company designated physician is entitled to total and permanent disability benefits. This principle was reiterated by the Supreme…
Read More
The execution bond requirement serves no legitimate purpose other than to delay the delivery of justice to seafarers who have already endured long and costly legal battles. Thus declared Federation of…
Read More
A claim for total and permanent disability benefits by a seafarer is governed by the 120/240 days rule. The summary of the rule was enunciated by the Supreme Court in…
Read More
The diagnosis of a seafarer’s personal doctor, even if made only after a single consultation, may be used as basis for the grant of disability benefits. The Supreme Court discussed…
Read More
The Magna Carta for Filipino Seafarers might turn out to be prejudicial to and discriminatory against disabled and sick seafarers instead of protecting them due to the execution bond. The…
Read More
Entitlement to disability benefits by seafarers is a matter governed not only by medical findings but also by law and by contract (OSG ShipMgt, vs De Jesus GR 207344, November 18, 2020). …
Read More
Pre-existing illness may be compensable if aggravated by the seafarer’s work. Thus ruled the Supreme Court in the case of seafarer Christopher Calera vs Hoegh Fleet Services Phil. (G.R. No. 250584,…
Read More
“Seafarers’ claims for disability benefits should not be considered unreasonable and impelled by nothing but greed but rather, justified by their health considerations and a natural desire of every person…
Read More
